Evidence map›Paper›PMID 36338553›Full record

ArticleThe Pan African medical journal2022

Primary diffuse large B-cell lymphoma of the right kidney: a case report.

Hamid Nasrollahi, Ali Eslahi, Faisal Ahmed, Bita Geramizadeh, Mansour Ansari

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hamid NasrollahiRadiation Oncology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali EslahiDepartment of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Faisal AhmedUrology Research Center, Al-Thora General Hospital, Department of Urology, School of Medicine, Ibb University of Medical Sciences, Ibb, Yemen.
Bita GeramizadehDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mansour AnsariRadiation Oncology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IRIbb University · YE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The existence of primary renal lymphoma (PRL) in the kidney has long been debated due to its extranodal location and lack of lymphatic channels. Primary renal lymphoma is extremely rare, accounting for less than 1%, and is frequently misdiagnosed as renal cell carcinoma (RCC). We present a 50-year-old man presenting with right flank pain in the last week. The computed tomography scan showed a large isodense right renal mass with a small para-aortic lymph node suspected of RCC. The patient underwent right radical nephrectomy and lymphadenectomy with an uneventful postoperative outcome. The histopathology and immunohistochemistry showed diffuse large B-cell lymphoma. Then, the patient received five-cycle chemotherapy and regional radiotherapy. Within five years of follow-up, no symptoms of recurrence. In conclusion, even though PRL is a rare tumor type. An effort should be made to make a preoperative diagnosis because PRL can be treated with systemic chemotherapy instead of other renal tumors requiring nephrectomy.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsLymphoma, Large B-Cell, DiffuseHumansKidneyMaleMiddle AgedNephrectomycase reportDiffuse large B-cell lymphomaprimary renal lymphoma

Identifiers

PMID36338553
PMCPMC9617495
OpenAlexW4290995269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.